New scrutiny mechanism and re-designation of NBs feature within a much changed EU medtech reg landscape
This article was originally published in Clinica
Executive Summary
The European Commission today published its much awaited proposals for a Regulation on medical devices and another on IVDs. This article looks in more detail at some of the far-reaching measures in the proposed medical devices Regulation and its impact on companies and other stakeholders in the medtech industry. Amanda Maxwell reports
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.